ArticleAIDS research and therapy2010

Continuing or adding IL-2 in patients treated with antiretroviral therapy (ACTG Protocol A5051, a rollover trial of ACTG Protocol A328).

Ronald J Bosch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.